Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Dow Jones pakils 100%?

Aspire Biopharma Announces $21 Million Private Placement by Select Investors, Strengthening Balance Sheet, Capital Position, and Fortifying Shareholder Equity to Meet Nasdaq Requirements

Dow Jones And U.S. Index Outlook: Hawkish NFP Sends Stocks Lower

Nasdaq 100: Final Stage Tech Bubble… or Once-in-a-Decade Buying Opportunity?

Treasuries Dip, Stocks Waver After US Jobs Surge: Markets Wrap